Alvotech On The Financing Trail Once More Amid Teva Commitment
Icelandic Firm To Issue More Convertible Bonds, Eyeing $100m Boost
Alvotech has its eyes on raising more cash to fund operations and ease the pain of missing out on an FDA approval for its Teva-partnered Humira (adalimumab) biosimilar.
